Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis

Published:2023-07-12 Issue:9 Volume:25 Page:959-967
ISSN:1523-3782
Container-title:Current Cardiology Reports
language:en
Short-container-title:Curr Cardiol Rep

Author:

Vasbinder Alexi,Ismail Anis,Salem Joe-Elie,Hayek Salim S.^ORCID

Funder

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Rogel Cancer Center, University of Michigan

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11886-023-01915-5.pdf

Reference76 articles.

1. Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol. 2020;17(12):725–41. https://doi.org/10.1038/s41571-020-0413-z.

2. Tan S, Day D, Nicholls SJ, Segelov E. Immune checkpoint inhibitor therapy in oncology: Current uses and future directions: JACC: CardioOncology State-of-the-Art Review. JACC: CardioOncol. 2022;4(5):579–97. https://doi.org/10.1016/j.jaccao.2022.09.004.

3. Wölffer M, Battke F, Schulze M, Feldhahn M, Flatz L, Martus P, et al. Biomarkers associated with immune-related adverse events under checkpoint inhibitors in metastatic melanoma. Cancers (Basel). 2022;14(2). https://doi.org/10.3390/cancers14020302.

4. Ruste V, Goldschmidt V, Laparra A, Messayke S, Danlos FX, Romano-Martin P, et al. The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry. Eur J Cancer. 2021;158:217–24. https://doi.org/10.1016/j.ejca.2021.08.048.

5. Zotova L. Immune checkpoint inhibitors-related myocarditis: A review of reported clinical cases. Diagnostics. 2023;13(7):1243.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review;Diagnostics;2024-08-16

2. Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab;Journal for ImmunoTherapy of Cancer;2024-08

3. Discovery of Plasma Proteins and Metabolites for Left Ventricular Cardiac Dysfunction in Pan-Cancer Patients;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3